Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer's disease.

Lewczuk PiotrNatalia ErmannUlf AndreassonChristian SchultheisJana PodhornaPhilipp SpitzerJuan Manuel MalerJohannes KornhuberKaj BlennowHenrik Zetterberg

Published in: Alzheimer's research & therapy (2018)

This study confirms increased concentrations of plasma NfL in patients with Alzheimer's disease compared with nondemented controls.

Keyphrases

cognitive decline
cerebrospinal fluid
mild cognitive impairment